top of page

Publications


We hope you find our list of research below informative. All have been peer-reviewed and published in academic journals.


Due to journal copyright restrictions, we can't link to the full texts of some publications. If you find that the full text isn't available in the link, send us an email and we will gladly send you a copy.

A trans woman gesturing with a pen while she reads a document. She has dyed pink hair and is wearing makeup.
pe_jo
Include Year Published
Include Categories
Results: 

80

7 December 2025
Effect of anti-androgens on body composition in transgender people: secondary analysis of a randomized clinical trial
VIEW
11 November 2025
Efficacy of a co-designed transgender health training program for primary care general practitioners
VIEW
29 August 2025
Advancing equity: the urgent need to include trans and gender diverse people in cervical cancer prevention in Australia
VIEW
25 July 2025
A systematic review of functional neurological disorder in transgender people
VIEW
3 April 2025
Internal barriers, external barriers, and bullying experiences among trans people in sport and fitness settings: associations with psychological distress and suicidality
VIEW
14 February 2025
Serum Estradiol Concentrations With Estradiol 0.06% Gel in Transgender and Gender-Diverse Adults
VIEW
10 February 2025
Laboratory Monitoring in Transgender and Gender-Diverse Individuals
VIEW
2 February 2025
Scalp hair parameter changes in transgender individuals commencing gender-affirming hormone therapy: A 24-week prospective observational study
VIEW
20 January 2025
The Gender Euphoria Scale (GES): development of a tool to measure gender euphoria
VIEW
16 December 2024
Effect of bicalutamide on serum total testosterone concentration in transgender adults: a case series
VIEW
11 December 2024
Exploring the role of sex hormones and gender diversity in multiple sclerosis
VIEW
28 October 2024
Participation, barriers, facilitators and bullying experiences of trans people in sport and fitness: findings from a national community survey of trans people in Australia
VIEW
25 October 2024
Testosterone and Quality of Life in Transgender and Gender-Diverse Adults Seeking Masculinization: A Secondary Analysis of a Randomized Clinical Trial
VIEW
25 October 2024
Safeguarding the health and wellbeing of transgender young people
VIEW
16 October 2024
Giant Intracranial Meningiomas Requiring Surgery in 2 Transgender Women Treated With Cyproterone Acetate
VIEW
15 October 2024
Language and terminology to describe transgender communities; Perspectives from people with lived experience
VIEW
17 September 2024
Effect of Spironolactone and Cyproterone Acetate on Breast Growth in Transgender People: A Randomized Clinical Trial
VIEW
17 September 2024
Persistent menstruation in transgender people using testosterone gender-affirming hormone therapy
VIEW
3 September 2024
Validation of Breast Idea Volume Estimator Application in Transfeminine People
VIEW
16 August 2024
Gender affirmation testosterone therapy, Australia, 2021–22: a review of PBS dispensing data
VIEW
26 July 2024
Gender-affirming hormone therapy for transgender and gender-diverse adults in Australia
VIEW
23 July 2024
Peri-operative care of transgender and gender-diverse individuals: guidance for clinicians and departments
VIEW
1 July 2024
Ensuring an inclusive, trans-led future for the field of trans health
VIEW
1 July 2024
Re: “Sublingual Estradiol Offers No Apparent Advantage over Combined Oral Estradiol and Cyproterone Acetate for Gender-Affirming Hormone Therapy of Treatment-Naive Trans Women: Results of a Prospective Pilot Study” by Yaish et al.
VIEW
11 June 2024
Adult Height in Transgender Youth Who Receive GnRH Analogues Followed by Gender-Affirming Hormone Therapy
VIEW
13 April 2024
Impact of Distinct Antiandrogen Exposures on the Plasma Metabolome in Feminizing Gender-affirming Hormone Therapy
VIEW
28 March 2024
Effect of Feminizing Hormone Therapy on QTc Interval: A Secondary Analysis of a Randomized Clinical Trial
VIEW
19 March 2024
Response to Letter to the Editor From Kirk & Stebbings: The Impact of Gender-Affirming Hormone Therapy on Physical Performance
VIEW
12 February 2024
Met and unmet need for medical gender affirmation in the Australian non-binary community.
VIEW
29 November 2023
Epidemiology of intensive care patients classified as a third sex in Australia and New Zealand.
VIEW
23 November 2023
Disruption of gender-affirming health care, and COVID-19 illness, testing, and vaccination among trans Australians during the pandemic.
VIEW
2 November 2023
Dermatological considerations for transgender and gender diverse patients.
VIEW
13 September 2023
Reversible Effects of Puberty Suppression on Bone Strength, Mass, and Body Composition in Adolescent Mice After Testosterone Therapy.
VIEW
7 September 2023
Early Access to Testosterone Therapy in Transgender and Gender-Diverse Adults Seeking Masculinization.
VIEW
11 August 2023
Estradiol Concentrations and Wellbeing in Trans People Using Estradiol Hormone Therapy.
VIEW
13 July 2023
The Impact of Gender-Affirming Hormone Therapy on Physical Performance.
VIEW
13 June 2023
Effect of gender-affirming hormone therapy on hair growth.
VIEW
8 June 2023
Implications of gender-affirming endocrine care for sports participation.
VIEW
3 April 2023
Pelvic Pain in Transgender People Using Testosterone Therapy.
VIEW
31 March 2023
Gender-Affirming Hormone Therapy for the Trans, Gender Diverse, and Nonbinary Community.
VIEW
8 February 2023
The Effect of Gender-Affirming Hormones on Gender Dysphoria, Quality of Life, and Psychological Functioning in Transgender Individuals.
VIEW
26 December 2022
Management of transgender patients in critical care.
VIEW
23 May 2022
Effects of low-dose oral micronised progesterone on sleep, psychological distress, and breast development in transgender individuals undergoing feminising hormone therapy.
VIEW
11 May 2022
Uncovering the effects of gender affirming hormone therapy on skeletal muscle and epigenetics.
VIEW
8 April 2022
Clinical features and prevalence of Klinefelter syndrome in transgender individuals.
VIEW
30 March 2022
Prescription Patterns and Testosterone Concentrations Achieved with AndroForte 5% Testosterone Cream in Transgender and Gender Diverse Individuals.
VIEW
11 March 2022
Testosterone concentrations and prescription patterns of 1% testosterone gel in transgender and gender diverse individuals.
VIEW
17 February 2022
Gender-affirming hormone therapy induces specific DNA methylation changes in blood.
VIEW
16 February 2022
Sex specific reference ranges and transgender care.
VIEW
3 January 2022
Bone Microarchitecture in Transgender Adults.
VIEW
23 November 2021
Testicular Cancer in Trans People Using Feminising Hormone Therapy.
VIEW
29 July 2021
Short-Term Effects of Gender-Affirming Hormone Therapy on Dysphoria and Quality of Life in Transgender Individuals.
VIEW
13 July 2021
Feminizing Hormone Therapy Prescription Patterns and Cardiovascular Risk Factors in Aging Transgender Individuals in Australia.
VIEW
18 June 2021
Selective Estrogen Receptor Modulators: A Potential Option For Non-Binary Gender-Affirming Hormonal Care?
VIEW
2 June 2021
Relationship Between Serum Estradiol Concentrations and Clinical Outcomes in Transgender Individuals Undergoing Feminizing Hormone Therapy.
VIEW
11 March 2021
The Impact of the First Three Months of the COVID-19 Pandemic on the Australian Trans Community.
VIEW
8 February 2021
Factors Associated with Suicide Attempts Among Australian Transgender Adults.
VIEW
23 January 2021
Insulin resistance in transgender individuals correlates with android fat mass.
VIEW
21 January 2021
Sexual Dimorphism in Innate Immunity: The Role of Sex Hormones and Epigenetics.
VIEW
12 January 2021
The Health and Well-Being of Transgender Australians: A National Community Survey.
VIEW
27 November 2020
Efficacy of Micronized Progesterone for Sleep.
VIEW
26 November 2020
The Informed Consent Model of Care for Accessing Gender-Affirming Hormone Therapy is Associated with High Patient Satisfaction.
VIEW
30 September 2020
Estradiol Therapy in the Perioperative Period: Implications for Transgender People Undergoing Feminizing Hormone Therapy.
VIEW
14 September 2020
A systematic review of antiandrogens and feminization in transgender women.
VIEW
18 August 2020
Approach to Interpreting Common Laboratory Pathology Tests in Transgender Individuals.
VIEW
10 June 2020
Testosterone therapy considerations in oestrogen, progesterone and androgen receptor-positive breast cancer in a transgender man.
VIEW
24 May 2020
Relationships between body mass index with oral estradiol dose and serum estradiol concentration in transgender adults undergoing feminising hormone therapy.
VIEW
15 May 2020
Global Coagulation Assays in Transgender Women on Oral and Transdermal Estradiol Therapy.
VIEW
13 April 2020
Non-Binary and Binary Gender Identity in Australian Trans and Gender Diverse Individuals.
VIEW
1 April 2020
Prevalence of polycythaemia with different formulations of testosterone therapy in transmasculine individuals.
VIEW
15 March 2020
Effects of gender-affirming hormone therapy on insulin resistance and body composition in transgender individuals.
VIEW
21 January 2020
Youths with a non-binary gender identity: a review of their sociodemographic and clinical profile.
VIEW
16 December 2019
Australian endocrinologists need more training in transgender health.
VIEW
13 December 2019
Health Needs of Trans and Gender Diverse Adults in Australia.
VIEW
15 November 2019
Prevalence of Autism Spectrum Disorder and Attention-Deficit Hyperactivity Disorder Amongst Individuals with Gender Dysphoria.
VIEW
4 July 2019
Position statement on the hormonal management of adult transgender and gender diverse individuals.
VIEW
1 July 2019
Cyproterone acetate or spironolactone in lowering testosterone concentrations for transgender individuals receiving oestradiol therapy.
VIEW
18 December 2018
Sociodemographic and Clinical Characteristics of Transgender Adults in Australia.
VIEW
14 August 2018
Gender-affirming hormone therapy and the risk of sex hormone-dependent tumours in transgender individuals.
VIEW
10 July 2018
Cross-sex hormone therapy in Australia: the prescription patterns of clinicians experienced in adult transgender healthcare.
VIEW

We Acknowledge the Traditional Custodians of the Lands and Waterways on which we work and pay our respects to Aboriginal and Torres Strait Islander Elders, past and present. Sovereignty was never ceded. This always was, and always will be, Aboriginal land. All information provided on this website is intended as a guide only. Please see your doctor for specific health advice for your individual circumstances. © 2026 Trans Health Research.

bottom of page